Since MMP‐9 inhibitor MMP9‐I is effective in blocking MMP‐9 protease activity [27, 32, 34], we also evaluated its effects on H3NT proteolysis in colon cancer cells as an extension of the knockdown studies. Here, MMP9 is linked to colonic neoplasm.